Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer (Q42444701)

From Wikidata
Jump to navigation Jump to search
scientific article published on 12 September 2013
edit
Language Label Description Also known as
English
Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer
scientific article published on 12 September 2013

    Statements

    Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit